A habitat-pathology-clinical transformer model for precision prognostication of neoadjuvant immunochemotherapy in ESCC

Esophageal squamous cell carcinoma (ESCC) shows marked inter-patient heterogeneity in response to neoadjuvant immunochemotherapy (NICT), highlighting the need for reliable pre-treatment predictors. In this multicenter study, 102 patients with advanced ESCC from two institutions were enrolled. Pre-treatment contrast-enhanced CT, whole-slide histopathology images, and clinical data were collected. Habitat-based radiomics was selected as the optimal imaging approach, with a Support Vector Machine (SVM) achieving an AUC of 0.723 (95% CI: 0.580–0.866) in the test cohort. For pathomics, the ResNet50-based multi-instance learning model with logistic regression was selected, achieving an AUC of 0.766 (95% CI: 0.639–0.894). These signatures were integrated with clinical features to develop HPTrans, a transformer-based multimodal model. HPTrans outperformed all single-modality approaches, achieving AUC of 0.921 (95% CI: 0.889–0.952) in the training cohort and 0.824 (95% CI: 0.720–0.928) in the test cohort. Collectively, HPTrans may aid pretreatment NICT response prediction and treatment selection in patients with advanced ESCC.

Authors

Institutions

Publication Details

Journal
iScience
Published
2026-11-17
DOI
https://doi.org/10.1016/j.isci.2026.118158
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A habitat-pathology-clinical transformer model for precision prognostication of neoadjuvant immunochemotherapy in ESCC

Wei Li, Qi Cao, Shenglong Xie, Gang Feng et al.
8 links
iScience
Radiomics and Machine Learning in Medical Imaging
article

A habitat-pathology-clinical transformer model for precision prognostication of neoadjuvant immunochemotherapy in ESCC

Wei Li, Qi Cao, Shenglong Xie, Gang Feng, Wenlei Lu, Zhiyang Li, Bin He
article en

Abstract

Esophageal squamous cell carcinoma (ESCC) shows marked inter-patient heterogeneity in response to neoadjuvant immunochemotherapy (NICT), highlighting the need for reliable pre-treatment predictors. In this multicenter study, 102 patients with advanced ESCC from two institutions were enrolled. Pre-treatment contrast-enhanced CT, whole-slide histopathology images, and clinical data were collected. Habitat-based radiomics was selected as the optimal imaging approach, with a Support Vector Machine (SVM) achieving an AUC of 0.723 (95% CI: 0.580–0.866) in the test cohort. For pathomics, the ResNet50-based multi-instance learning model with logistic regression was selected, achieving an AUC of 0.766 (95% CI: 0.639–0.894). These signatures were integrated with clinical features to develop HPTrans, a transformer-based multimodal model. HPTrans outperformed all single-modality approaches, achieving AUC of 0.921 (95% CI: 0.889–0.952) in the training cohort and 0.824 (95% CI: 0.720–0.928) in the test cohort. Collectively, HPTrans may aid pretreatment NICT response prediction and treatment selection in patients with advanced ESCC.

iScienceVol. 29(12)
University of Electronic Science and Technology of China (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (CN)
Department of Science and Technology of Sichuan Province
Good health and well-being
Radiomics and Machine Learning in Medical Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon